ATR
Medical Instruments & Supplies · Healthcare
CEO, Board Member
2026-09-01–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Aptargroup, Inc. publishes a filing, an earnings call transcript or a press release.
Get ATR alertsGael Touya is recorded as CEO and Board Member at Aptargroup, Inc. (ATR) since September 1, 2026. Aptargroup, Inc. reported in an 8-K filed September 1, 2026 that Gael Touya was appointed President and Chief Executive Officer, effective September 1, 2026. Aptargroup, Inc. reported in an 8-K filed September 1, 2026 that Gael Touya was appointed director, effective September 1, 2026. Aptargroup, Inc. reported in an 8-K filed March 17, 2026 that Gael Touya was appointed President and Chief Executive Officer, effective September 1, 2026. The proxy statement of Aptargroup, Inc. reports total compensation of $2,664,092 for Gael Touya in fiscal 2020, including a base salary of $570,544. Disclosed compensation is on record for 3 fiscal years. Gael Touya has spoken on 1 investor event across 1 company, most recently for Aptargroup, Inc. on September 9, 2026. Aptargroup, Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Aptargroup, Inc. includes Daniel Ackerman (Chief Accounting Officer), B. Craig Owens (Board Member), Candace Matthews (Board Member) and 7 others.
“Mr. Touya, who previously served as President of the Company’s Aptar Pharma segment, became President and Chief Executive Officer of the Company effective September 1, 2026, succeeding Stephan B. Tanda, who retired from that position on such date.”
“the Board of Directors (the “Board”) of AptarGroup, Inc. (the “Company”) increased the size of the Board from ten (10) to eleven (11) directors and appointed Gael Touya as a director, effective as of September 1, 2026.”
“Again not asking you to grade anyone but as you're going through that process and I guess in fairness Beauty has had a couple of stumbles here in the past couple years some of which were outside of Aptar's control but just things that you're looking at within those two segments that you're like I said maybe couldn't…”
2026-09-01–present
2026-09-01–present
Proxy statement
Start not stated–present
Last confirmed March 26, 2021
ATR
Medical Instruments & Supplies · Healthcare
CEO, Board Member
2026-09-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Aptargroup, Inc. (ATR) | President, Aptar Food + Beverage | $570,544 | $2,664,092 |
| 2019 | Aptargroup, Inc. (ATR) | President, Aptar Food + Beverage | $523,966 | $3,310,694 |
| 2018 | Aptargroup, Inc. (ATR) | President, Aptar Food + Beverage | $515,841 | $1,948,094 |